EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial

Niko Kaciroti, Phillip D Levy, Kenneth A Jamerson, Robert D Brook iD

The Journal of Clinical Hypertension · 2026-05 · 28 (5)

DOI: 10.1111/jch.70278 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Hypertension, online erschienen am 13.05.2026. Verfasst von Niko Kaciroti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Biostatistics, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Amlodipine, Antihypertensive Agents, Machine Learning, Hypertension. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS, American Heart Association, National Institute on Minority Health and Health Disparities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Results from the ACCOMPLISH (Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension) trial suggest that combining benazepril with amlodipine, rather than hydrochlorothiazide, provides superior cardiovascular protection potentially in a BP‐independent manner. We employed random survival forest, a powerful machine learning approach, to compare the relative importance of risk factors (i.e., variable importance factor (VIF)), focusing on in‐trial BP control for predicting the primary composite cardiovascular outcome in the 2 treatment limbs. Among the 6 risk factors with significantly different VIFs between treatments, all were lower under benazepril/amlodipine combination. The VIF for achieved systolic BP at 6‐months was 35% lower in the benazepril/amlodipine (0.082) versus the benazepril/hydrochlorothiazide (0.126) limb. The fact that in‐trial BP control was less important for preventing cardiovascular events during benazepril/amlodipine treatment provides novel support for our contention that this combination regimen provides a degree of clinically‐relevant cardio‐protective actions in a BP‐independent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmlodipineAntihypertensive AgentsMachine LearningHypertensionBenzazepinesCardiovascular DiseasesHumansHydrochlorothiazideDrug Therapy, CombinationBlood PressureHeart Disease Risk FactorsFemaleMaleRisk Factors

Stichwörter der Autor:innen

clinical trialscombination antihypertensive therapymachine learning

Substanzen

benazeprilAmlodipineAntihypertensive AgentsHydrochlorothiazideBenzazepines

Autor:innen und Institutionen

  • Departments of Pediatrics and Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
  • Integrative Biosciences Center, Wayne State University, Detroit, Michigan, USA.
  • Department of Emergency Medicine, Wayne State University, Detroit, Michigan, USA.
  • Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Division of Cardiovascular Disease, Department of Internal Medicine, Wayne State University, Detroit, Michigan, USA.

ORCID-Profile: Robert D Brook

Förderung

  • NIMHD NIH HHS
  • American Heart Association
  • National Institute on Minority Health and Health Disparities

Zitieren

APA

Kaciroti, N., Levy, P. D., Jamerson, K. A., & Brook, R. D. (2026). Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial. The Journal of Clinical Hypertension, 28(5). https://doi.org/10.1111/jch.70278

Vancouver

Kaciroti N, Levy PD, Jamerson KA, Brook RD. Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial. The Journal of Clinical Hypertension. 2026;28(5). doi:10.1111/jch.70278

BibTeX
@article{Kaciroti2026,
  author = {Kaciroti, Niko and Levy, Phillip D and Jamerson, Kenneth A and Brook, Robert D},
  title = {Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial},
  journal = {The Journal of Clinical Hypertension},
  year = {2026},
  volume = {28},
  number = {5},
  doi = {10.1111/jch.70278}
}
Kostenlos starten →